BIOMEBANK
BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positioning the drug product for multiple indications. Furthermore, we are actively developing second generation therapies in multiple diseases, including Ulcerative Colitis and Crohn's Disease.
BIOMEBANK
Industry:
Biopharma Biotechnology Manufacturing
Founded:
2018-01-01
Address:
Adelaide, South Australia, Australia
Country:
Australia
Total Employee:
11+
Status:
Active
Contact:
08 8152 9370
Email Addresses:
[email protected]
Similar Organizations
Amino Medical Science
Amino Medical Science is a clinical stage biotechnology company that pioneers first-in-class therapeutic treatments
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
miRecule
MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics.